1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. IN-VITRO TOXICOLOGY TESTING MARKET BY PRODUCT
5.1. Introduction
5.2. Assays
5.2.1. Market Trends and Opportunities
5.2.2. Growth Prospects
5.3. Software
5.3.1. Market Trends and Opportunities
5.3.2. Growth Prospects
5.4. Consumables
5.4.1. Market Trends and Opportunities
5.4.2. Growth Prospects
5.5. Services
5.5.1. Market Trends and Opportunities
5.5.2. Growth Prospects
5.6. Instruments
5.6.1. Market Trends and Opportunities
5.6.2. Growth Prospects
6. IN-VITRO TOXICOLOGY TESTING MARKET BY TECHNOLOGY
6.1. Introduction
6.2. OMICS Technology
6.2.1. Market Trends and Opportunities
6.2.2. Growth Prospects
6.3. Cell Culture Technology
6.3.1. Market Trends and Opportunities
6.3.2. Growth Prospects
6.4. High Throughput Technology
6.4.1. Market Trends and Opportunities
6.4.2. Growth Prospects
6.5. Molecular Imaging Technology
6.5.1. Market Trends and Opportunities
6.5.2. Growth Prospects
7. IN-VITRO TOXICOLOGY TESTING MARKET BY METHOD
7.1. Introduction
7.2. In Silico
7.2.1. Market Trends and Opportunities
7.2.2. Growth Prospects
7.3. Biochemical Assay
7.3.1. Market Trends and Opportunities
7.3.2. Growth Prospects
7.4. Cellular Assay
7.4.1. Market Trends and Opportunities
7.4.2. Growth Prospects
7.5. Ex-vivo
7.5.1. Market Trends and Opportunities
7.5.2. Growth Prospects
8. IN-VITRO TOXICOLOGY TESTING MARKET BY APPLICATION
8.1. Introduction
8.2. Endocrine Disruption
8.2.1. Market Trends and Opportunities
8.2.2. Growth Prospects
8.3. Dermal Toxicity
8.3.1. Market Trends and Opportunities
8.3.2. Growth Prospects
8.4. Systemic Toxicology
8.4.1. Market Trends and Opportunities
8.4.2. Growth Prospects
8.5. Ocular Toxicity
8.5.1. Market Trends and Opportunities
8.5.2. Growth Prospects
8.6. Others
8.6.1. Market Trends and Opportunities
8.6.2. Growth Prospects
9. IN-VITRO TOXICOLOGY TESTING MARKET BY END-USER
9.1. Introduction
9.2. Cosmetics & Household Products
9.2.1. Market Trends and Opportunities
9.2.2. Growth Prospects
9.3. Pharmaceutical Industry
9.3.1. Market Trends and Opportunities
9.3.2. Growth Prospects
9.4. Diagnostics
9.4.1. Market Trends and Opportunities
9.4.2. Growth Prospects
9.5. Academic Institutes & Research Laboratories
9.5.1. Market Trends and Opportunities
9.5.2. Growth Prospects
9.6. Food Industry
9.6.1. Market Trends and Opportunities
9.6.2. Growth Prospects
9.7. Chemicals Industry
9.7.1. Market Trends and Opportunities
9.7.2. Growth Prospects
9.8. Others
9.8.1. Market Trends and Opportunities
9.8.2. Growth Prospects
10. IN-VITRO TOXICOLOGY TESTING MARKET BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. By Product
10.2.2. By Technology
10.2.3. By Method
10.2.4. By Application
10.2.5. By End-User
10.2.6. By Country
10.2.6.1. United States
10.2.6.1.1. Market Trends and Opportunities
10.2.6.1.2. Growth Prospects
10.2.6.2. Canada
10.2.6.2.1. Market Trends and Opportunities
10.2.6.2.2. Growth Prospects
10.2.6.3. Mexico
10.2.6.3.1. Market Trends and Opportunities
10.2.6.3.2. Growth Prospects
10.3. South America
10.3.1. By Product
10.3.2. By Technology
10.3.3. By Method
10.3.4. By Application
10.3.5. By End-User
10.3.6. By Country
10.3.6.1. Brazil
10.3.6.1.1. Market Trends and Opportunities
10.3.6.1.2. Growth Prospects
10.3.6.2. Argentina
10.3.6.2.1. Market Trends and Opportunities
10.3.6.2.2. Growth Prospects
10.3.6.3. Others
10.3.6.3.1. Market Trends and Opportunities
10.3.6.3.2. Growth Prospects
10.4. Europe
10.4.1. By Product
10.4.2. By Technology
10.4.3. By Method
10.4.4. By Application
10.4.5. By End-User
10.4.6. By Country
10.4.6.1. United Kingdom
10.4.6.1.1. Market Trends and Opportunities
10.4.6.1.2. Growth Prospects
10.4.6.2. Germany
10.4.6.2.1. Market Trends and Opportunities
10.4.6.2.2. Growth Prospects
10.4.6.3. France
10.4.6.3.1. Market Trends and Opportunities
10.4.6.3.2. Growth Prospects
10.4.6.4. Italy
10.4.6.4.1. Market Trends and Opportunities
10.4.6.4.2. Growth Prospects
10.4.6.5. Spain
10.4.6.5.1. Market Trends and Opportunities
10.4.6.5.2. Growth Prospects
10.4.6.6. Others
10.4.6.6.1. Market Trends and Opportunities
10.4.6.6.2. Growth Prospects
10.5. Middle East and Africa
10.5.1. By Product
10.5.2. By Technology
10.5.3. By Method
10.5.4. By Application
10.5.5. By End-User
10.5.6. By Country
10.5.6.1. Saudi Arabia
10.5.6.1.1. Market Trends and Opportunities
10.5.6.1.2. Growth Prospects
10.5.6.2. UAE
10.5.6.2.1. Market Trends and Opportunities
10.5.6.2.2. Growth Prospects
10.5.6.3. Others
10.5.6.3.1. Market Trends and Opportunities
10.5.6.3.2. Growth Prospects
10.6. Asia Pacific
10.6.1. By Product
10.6.2. By Technology
10.6.3. By Method
10.6.4. By Application
10.6.5. By End-User
10.6.6. By Country
10.6.6.1. Japan
10.6.6.1.1. Market Trends and Opportunities
10.6.6.1.2. Growth Prospects
10.6.6.2. China
10.6.6.2.1. Market Trends and Opportunities
10.6.6.2.2. Growth Prospects
10.6.6.3. India
10.6.6.3.1. Market Trends and Opportunities
10.6.6.3.2. Growth Prospects
10.6.6.4. South Korea
10.6.6.4.1. Market Trends and Opportunities
10.6.6.4.2. Growth Prospects
10.6.6.5. Taiwan
10.6.6.5.1. Market Trends and Opportunities
10.6.6.5.2. Growth Prospects
10.6.6.6. Thailand
10.6.6.6.1. Market Trends and Opportunities
10.6.6.6.2. Growth Prospects
10.6.6.7. Indonesia
10.6.6.7.1. Market Trends and Opportunities
10.6.6.7.2. Growth Prospects
10.6.6.8. Others
10.6.6.8.1. Market Trends and Opportunities
10.6.6.8.2. Growth Prospects
11. COMPETITIVE ENVIRONMENT AND ANALYSIS
11.1. Major Players and Strategy Analysis
11.2. Market Share Analysis
11.3. Mergers, Acquisitions, Agreements, and Collaborations
11.4. Competitive Dashboard
12. COMPANY PROFILES
12.1. Abbott Laboratories
12.2. Agilent Technologies
12.3. Bio-Rad Laboratories
12.4. Covance
12.5. Eurofins Scientific
12.6. GE Healthcare
12.7. Merck KGaA
12.8. Promega Corporation
12.9. Quest Diagnostics
12.10. Thermo Fisher Scientific